Is weekly dose of adalimumab a simple approach for resistant psoriasis?
CONCLUSION: We demonstrate that a dose escalation of adalimumab may be taken into consideration also for those patients who failed to respond to standard dosage of the same molecule.
PMID: 28777015 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Arthritis | Dermatology | Disability | Humira | Psoriasis | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Skin